TGF-β-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells

Cancer Letters

Volumn 252, Issue 1, 2007, Pages 147-156

  Kim, Eun Sook ^a   Sohn, Yeo Won ^b   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

AP 1; ATF2; Breast epithelial cells; MMP; p38 MAPK; TGF

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GELATINASE A; PROTEIN P53; TRANSCRIPTION FACTOR PEA3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING SITE; BREAST EPITHELIUM; DNA BINDING; ELECTROPHORETIC MOBILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 2; BINDING SITES; BREAST; BREAST NEOPLASMS; CELL LINE; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA2;

EID: 34248401646     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.12.016     Document Type: Article

References (45)

1. Tryggvason K., Hoyhtya M., and Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res. Treat. 24 (1993) 209-218
2. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., and Seiki M.A. Matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370 (1994) 61-65
3. McCawley L.J., and Matrisian L.M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol. Med. Today 4 (2000) 149-156
4. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6 (1990) 597-641
5. Datto M.B., Li Y., Panus J.F., Howe D.J., Xiong Y., and Wang X.F. Transforming growth factor-beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92 (1995) 5545-5549
6. Reiss M., and Barcellos-Hoff M.H. Transforming growth factor-beta in breast cancer: a working hypothesis. Breast Cancer Res. Treat. 45 (1997) 81-95
7. Akhurst R.J., and Balmain A. Genetic events and the role of TGF-beta in epithelial tumour progression. J. Pathol. 187 (1999) 82-90
8. Kim E.S., Kim M.S., and Moon A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int. J. Oncol. 25 (2004) 1375-1382
9. Kim E.S., Kim M.S., and Moon A. Transforming growth factor (TGF)-β in conjunction with H-Ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine 29 (2005) 84-91
10. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X.F., and Massague J. TGF-beta signals through a heteromeric protein kinase receptor complex. Cell 71 (1992) 1003-1014
11. Mulder K. Role of Ras and Mapks in TGF-beta signaling. Cytokine Growth Factor Rev. 11 (2000) 23-25
12. Yu L., Hebert M.C., and Zhang Y.E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21 (2002) 3749-3759
13. Keeton M.R., Curriden S.A., Van Zonneveld A.J., and Loskutoff D.J. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor-beta. J. Biol. Chem. 266 (1991) 23048-23052
14. Campbell C.E., Flenniken A.M., Skup D., and Williams B.R. Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J. Biol. Chem. 266 (1991) 7199-7206
15. Mauviel A., Chung K.Y., Agarwal A., Tamai K., and Uitto J. Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-beta in fibroblasts and keratinocytes. J. Biol. Chem. 271 (1996) 10917-10923
16. Chung K.Y., Agarwal A., Uitto J., and Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J. Biol. Chem. 271 (1996) 3272-3278
17. Pesce C.G., Nogues G., Alonso C.R., Baralle F.E., and Kornblihtt A.R. Interaction between the (-170) CRE and the (-150) CCAAT box is necessaryfor efficient activation of the fibronectin gene promoter by cAMP and ATF-2. FEBS Lett. 457 (1999) 445-451
18. Beier F., Lee R.J., Taylor A.C., Pestell R.G., and LuValle P. Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc. Natl. Acad. Sci. USA 96 (1999) 1433-1438
19. Beier F., Taylor A.C., and LuValle P. Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes. J. Biol. Chem. 275 (2000) 12948-12953
20. Sano Y., Harada J., Tashiro S., Gotoh-Mandeville R., Maekawa T., and Ishii S. ATF2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling. J. Biol. Chem. 274 (1999) 8949-8957
21. Ionescu A.M., Schwarz E.M., Zuscik M.J., Drissi H., Puzas J.E., Rosier R.N., and O'Keefe R.J. ATF2 cooperates with Smad3 to mediate TGF-beta effects on chondrocyte maturation. Exp. Cell Res. 288 (2003) 198-207
22. Song H., Ki S.H., Kim S.G., and Moon A. Activating transcription factor (ATF)2 mediates MMP-2 transcriptional activation induced by p38 MAPK in breast epithelial cells. Cancer Res. 66 (2006) 10487-10496
23. Soule H.D., Maloney T.M., Wolman S.R., Peterson W.D., Brenz Jr. R., and McGrath C.M. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50 (1990) 6075-6086
24. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., and Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270 (1995) 7420-7426
25. Ahn S., Olive M., Aggarwal S., Krylov D., Ginty D.D., and Vinson C. A dominant-negative inhibitor of CREN reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol. Cell Biol. 2 (1998) 967-977
26. Sabeh F., Ota I., Holmbeck K., Birkedal-Hansen H., Soloway P., Balbin M., Lopez-Otin C., Shapiro S., Inada M., Krane S., Allen E., Chung D., and Weiss S.J. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167 (2004) 769-781
27. Kim M.S., Lee E.J., Kim H.R., and Moon A. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 63 (2003) 5454-5461
28. Moon A., Kim M.S., Kim T.G., Kim S.H., Kim H.E., Chen Y.Q., and Kim H.R. H-Ras, but not N-Ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-Ras-induced invasive phenotype. Int. J. Cancer 85 (2000) 176-181
29. Bian J., and Sun Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell Biol. 17 (1997) 6330-6338
30. Qin H., Sun Y., and Benveniste E.N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem. 274 (1999) 29130-29137
31. Ma Z., Qin H., and Benveniste E.N. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J. Immunol. 167 (2001) 5150-5159
32. Ki S.H., Cho I.J., Choi D.W., and Kim S.G. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression. Mol. Cell Biol. 10 (2005) 4150-4165
33. Sehgal I., and Thompson T.C. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol. Biol. Cell 10 (1999) 407-416
34. Bergma M.R., Cheng S., Honbo N., Piacentini L., Karliner J.S., and Lovett D.H. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem. J. 369 (2003) 485-496
35. Finlay G.A., Thannickal V.J., Fanburg B.L., and Paulson K.E. Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J. Biol. Chem. 275 (2000) 27650-27656
36. Brodin G., Ahgren A., ten Dijke P., Heldin C.H., and Heuchel R. Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter. J. Biol. Chem. 275 (2000) 29023-29030
37. Shaulian E., and Karin M. AP-1 in cell proliferation and survival. Oncogene 20 (2001) 2390-2400
38. Herdegen T., and Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28 (1998) 370-490 Review
39. Lai C.F., Feng X., Nishimura R., Teitelbaum S.L., Avioli L.V., Ross F.P., and Cheng S.L. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. J. Biol. Chem. 275 (2000) 36400-36406
40. Pardali K., Kurisaki A., Moren A., ten Dijke P., Kardassis D., and Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J. Biol. Chem. 275 (2000) 29244-29256
41. Jungert K., Buck A., Buchholz M., Wagner M., Adler G., Gress T.M., and Ellenrieder V. Smad-Sp1 complexes mediate TGF-beta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis (2006) 2392-2401
42. Akhurst R.J. TGF-beta antagonists: why suppress a tumor suppressor?. J. Clin. Invest. 109 (2002) 533-1536
43. Wakefield L.M., and Roberts A.B. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12 (2002) 22-29
44. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., and Engel M.E. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12 (2001) 27-36
45. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., and Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor-beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275 (2000) 36803-36810